Back
Amicus Therapeutics Stock Price Chart
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Buy
63
FOLD
Amicus Therapeutics
Last Price:
11.22
Seasonality Move:
8.32%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade- The current trend is moderately bearish and FOLD is experiencing buying pressure, which is a positive indicator for future bullish movement.
Amicus Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.53 | Buy |
| 20-day SMA: | 11.16 | Buy |
| 50-day SMA: | 11.14 | Buy |
| 200-day SMA: | 11.13 | Buy |
| 8-day EMA: | 11.51 | Buy |
| 20-day EMA: | 11.31 | Buy |
| 50-day EMA: | 11.12 | Buy |
| 200-day EMA: | 11.12 | Buy |
Amicus Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.19 | Buy |
| Relative Strength Index (14 RSI): | 58.72 | Buy |
| Chaikin Money Flow: | 1894997 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.37 - 11.69) | Buy |
| Bollinger Bands (100): | (10.14 - 11.52) | Buy |
Amicus Therapeutics Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Amicus Therapeutics Stock
Is Amicus Therapeutics Stock a Buy?
- Amicus Therapeutics share price is 11.74 while FOLD 8-day simple moving average is 11.53, which is a Buy signal.
- The stock price of FOLD is 11.74 while Amicus Therapeutics 20-day SMA is 11.16, which makes it a Buy.
- Amicus Therapeutics 50-day simple moving average is 11.14 while FOLD share price is 11.74, making it a Buy technically.
- FOLD stock price is 11.74 and Amicus Therapeutics 200-day simple moving average is 11.13, creating a Buy signal.
FOLD Technical Analysis vs Fundamental Analysis
Buy
63
Amicus Therapeutics (FOLD)
is a Buy
Is Amicus Therapeutics a Buy or a Sell?
-
Amicus Therapeutics stock is rated a Buy
The current Amicus Therapeutics [FOLD] share price is $11.74. The Score for FOLD is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
Amicus Therapeutics Stock Info
Market Cap:
3.48B
Price in USD:
11.74
Share Volume:
1.97M
Amicus Therapeutics 52-Week Range
52-Week High:
14.57
52-Week Low:
9.02
Buy
63
Amicus Therapeutics (FOLD)
is a Buy
Amicus Therapeutics Share Price Forecast
-
What is the Amicus Therapeutics stock price today?
The Amicus Therapeutics stock price is 11.74 USD today. -
Will FOLD stock go up or go down?
Amicus Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Amicus Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Amicus Therapeutics is not overvalued.
Is Amicus Therapeutics Stock a Buy?
- Amicus Therapeutics share price is 11.74 while FOLD 8-day exponential moving average is 11.51, which is a Buy signal.
- The stock price of FOLD is 11.74 while Amicus Therapeutics 20-day EMA is 11.31, which makes it a Buy.
- Amicus Therapeutics 50-day exponential moving average is 11.12 while FOLD share price is 11.74, making it a Buy technically.
- FOLD stock price is 11.74 and Amicus Therapeutics 200-day simple moving average is 11.12, creating a Buy signal.
Fundamental Analysis of Amicus Therapeutics
Is Amicus Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.53 per share, and an increase next year of $0.28 per share.
Technical Analysis of Amicus Therapeutics
Should I short Amicus Therapeutics stock?
- FOLD Moving Average Covergence Divergence (MACD) indicator is 0.19, suggesting Amicus Therapeutics is a Buy
- Amicus Therapeutics Relative Strength Index (RSI) is 58.72, which suggest Amicus Therapeutics is overbought
- The Bollinger Bands (25) for Amicus Therapeutics is (10.37 - 11.69), which suggest Amicus Therapeutics is a Buy
- The Bollinger Bands (100) for Amicus Therapeutics is (10.14 - 11.52), which suggest Amicus Therapeutics is a Buy
* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.